JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A8346 BYL-719
1 Citation

Target: PI3K

Summary: Selective PI3Kα inhibitor

≥22.07 mg/mL
A8354 A66

Target: PI3K

Summary: P110α inhibitor

insoluble in H2O; ≥19.7 mg/mL
A8373 AZD2014

Summary: Novel mTOR inhibitor

≥23.15 mg/mL
A8488 NVP-BGT226

Target: PI3K|mTOR

Summary: PI3K/mTOR inhibitor,selective and novel

insoluble in EtOH; insoluble in H2O; ≥16.28 mg/mL
A8499 PF-04691502

Target: Akt|PI3K|mTOR

Summary: PI3K/mTOR (FRAP) inhibitor

insoluble in H2O; insoluble in EtOH; ≥10.63 mg/mL
A8505 PKI-402

Summary: PI3K inhibitor,selective, reversible and ATP-competitive

insoluble in EtOH; insoluble in H2O; ≥14.28 mg/mL
A8541 Triciribine
5 Citation

Summary: Akt inhibitor,highly selective

insoluble in H2O; insoluble in EtOH; ≥118.4 mg/mL
A8395 CHIR-98014

Target: GSK-3

Summary: GSK-3β inhibitor,selective and ATP-competitive

insoluble in H2O; insoluble in EtOH; ≥8.1 mg/mL
A8396 CHIR-99021 (CT99021) HCl

Target: GSK-3

Summary: GSK-3α/β inhibitor

≥25.1 mg/mL
A8551 INK 128 (MLN0128)
4 Citation

Target: mTOR

Summary: MTOR(TORC-1/-2) inhibitor,potent and selective

insoluble in H2O; ≥15.45 mg/mL